Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET

Rhea-AI Summary

Plus Therapeutics (NASDAQ:PSTV), a clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics for central nervous system (CNS) cancers, will host a business update conference call on Thursday, June 26, 2025, at 9:00 AM ET.

The company will release its business update before market open, followed by a conference call and webcast where management will provide additional details. Participants are encouraged to pre-register through the provided dial-in link, and should join 15 minutes before the start time. A replay will be available on the company's website for 90 days following the live call.

HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announces that the Company will provide a business update on Thursday, June 26, 2025 before the market open. Plus Therapeutics’ management team will then host a conference call and webcast at 9:00 a.m. ET to discuss and provide additional details.

Webcast and Conference Call

	Date/Time:	Thursday, June 26, 2025 @ 9:00 AM ET
	Webcast:	https://edge.media-server.com/mmc/p/97egitn8
	Dial-in Link:	https://register-conf.media-server.com/register/BI66b197347e6041329ab814378ea34059

Participants are encouraged to pre-register any time before the call through the dial-in link. Once registration is completed, participants will be provided a dial-in number with a personalized conference code to access the call. Please dial in 15 minutes prior to the start time.

Following the live call, a replay will be available on the Company’s website under the ‘For Investors’ section. The webcast will be available on the Company’s website for 90 days following the live call.

About Plus Therapeutics
Headquartered in Houston, Texas, Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes. Combining image-guided local beta radiation and targeted drug delivery approaches, the Company is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). The Company has built a supply chain through strategic partnerships that enable the development, manufacturing, and future potential commercialization of its products. For more information, visit https://www.plustherapeutics.com.

Investor Contact
CORE IR
investor@plustherapeutics.com

FAQ

When is Plus Therapeutics (PSTV) hosting its business update conference call?

Plus Therapeutics will host its business update conference call on Thursday, June 26, 2025 at 9:00 AM ET, with the business update being released before market open.

How can investors access Plus Therapeutics' (PSTV) conference call?

Investors can access the call through the webcast link at edge.media-server.com or by pre-registering through the dial-in link. A replay will be available on the company's website for 90 days after the live call.

What is Plus Therapeutics' (PSTV) main business focus?

Plus Therapeutics is a clinical-stage pharmaceutical company that develops targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers.

How long will the PSTV conference call replay be available?

The conference call webcast replay will be available on Plus Therapeutics' website under the 'For Investors' section for 90 days following the live call.